SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED
GMED 72.00+0.5%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Koerte Andreas who wrote (49)1/17/1998 1:00:00 PM
From: Jonathan Lester  Read Replies (1) of 63
 
Spoke to IR at company on Friday. They did not know of any news or developments to prompt the sell off. They said that the IL-2 trials are on schedule and that some results should be out in a few months. The deal with BM cannot be cancelled. BM has an option to expand the partnership for cancer therapy, but the option runs out in Feb 98, and nothing has been done at this time. Hope this info helps. I am long GMED and would like to see gene therapy make it to market, although this may take many years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext